At the beginning of 2022, institutions have begun intensive research on listed companies. Deng Xiaofeng of Gaoyi assets, Xie Zhiyu of Xingzheng Global Fund, relocation of Xingzheng Global Fund, Zheng Lei of huitianfu fund, Yu Haifeng of Shenzhi assets and other star fund managers in charge of more than 10 billion funds appear in the research list of listed companies. On the whole, the hot stocks with more recent stock price correction have become the key research targets of the above fund managers. In addition, the fund’s 2021 fourth quarter report recently opened, and hot stocks have also become a key topic of discussion for fund managers.
intensive research by star fund managers
The adjustment of popular stocks has attracted the attention of many star fund managers.
Take Nantong Jianghai Capacitor Co.Ltd(002484) in the aluminum electrolytic capacitor industry as an example, its share price increased by more than 160% in 2021, and the share price has been callback by more than 10% since 2022. On January 11, Nantong Jianghai Capacitor Co.Ltd(002484) teleconference attracted many institutions. Boshi fund, Xingshi investment, huitianfu fund, Dunhe assets, Fuguo fund, Xingzheng Global Fund and other head institutions appeared in the research list. Among them, Hua’an Hu Yibin, Ping’an shenaiqian, Xingzheng global Xie Zhiyu, Fuguo Pu Shilin, huitianfu Zhao Pengfei and other fund managers personally participated.
In addition to the investigation Nantong Jianghai Capacitor Co.Ltd(002484) , Xie Zhiyu investigated Apeloa Pharmaceutical Co.Ltd(000739) twice this year. From the perspective of stock price trend, Apeloa Pharmaceutical Co.Ltd(000739) can be described as a proper Bull Stock. The stock price has increased nearly five times since 2019, but its recent stock price performance is poor, retreating more than 20% since the high point in December last year. It is worth noting that Apeloa Pharmaceutical Co.Ltd(000739) is also Xie Zhiyu’s heavy position stock. As of the end of the third quarter of last year, Xingquan Herun and Xingquan Heyi funds managed by Xie Zhiyu held more than 20 million shares.
In addition, 10 billion fund managers such as Xingzheng global housewarming, Cathay Pacific Chengzhou, huitianfu Zheng Lei and Shenzhi asset Yu Haifeng also participated in the research of Apeloa Pharmaceutical Co.Ltd(000739) .
Similar to Zhejiang Tony Electronic Co.Ltd(603595) , the company’s main products include ultra-fine electronic wires and diamond cutting wires. Since May last year, its share price has exploded, with an increase of more than 200%. Since then, the share price has been sharply adjusted, and the share price has fallen by more than 30% since December last year. On January 11, Huaxia Fund, Gaoyi assets, Chongyang investment, China Europe Fund and other well-known institutions conducted research on it. Among them, Deng Xiaofeng, chief investment officer of Gaoyi assets, rarely appeared.
Is there a chance after the correction of hot stocks?
Is there a chance after the correction of popular stocks? PanYao assets said that more investment opportunities this year still lie in the boom track after the correction. Among them, the military industry is a new year, and new energy and semiconductors may encounter a differentiated market. “At present, we are also gradually adding positions to these oversold boom stocks. At the same time, we are also actively arranging some industries with low valuation and reversal of prosperity, such as class II vaccine, traditional Chinese medicine, rehabilitation and elderly care in medicine.”
In fact, in the recently disclosed fourth quarter report of 2021 of some funds, fund managers also talked about their views on popular tracks and popular stocks.
Chi chensen, manager of Anxin medical health fund, said that in the fourth quarter, he still adhered to a more balanced allocation on the whole, gradually realized the income on some high boom track targets with over valuation, excavated some high growth targets with undervalued value at the bottom, and increased the allocation in sectors such as traditional Chinese medicine and low value consumables. In the first quarter of 2022, we will still adhere to a more balanced allocation and actively distribute some stocks of non popular tracks with low valuation and good growth. After adjustment, the targets of some high boom tracks have gradually entered the configurable areas.
From the change of top ten heavyweight stocks of Anxin pharmaceutical health, by the end of the fourth quarter of 2021, Guilin Sanjin Pharmaceutical Co.Ltd(002275) , Hunan Jiudian Pharmaceutical Co.Ltd(300705) , Guizhou Xinbang Pharmaceutical Co.Ltd(002390) , Zhende Medical Co.Ltd(603301) , Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) , China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) had become the top ten heavyweight stocks of the fund.
Shi Cheng, advanced manufacturing fund manager of SDIC UBS, achieved high returns last year with his heavy position in the new energy sector. He said that at present, he is more optimistic about the wind power and photovoltaic industries and will continue to observe. The TMT industry still focuses on smart vehicles, and the market share of electric vehicles continues to increase. However, due to a certain increase in the price of power batteries in the future, and the cost will continue, it will take time for the profit to be greatly reflected, and the speed of intelligent promotion remains to be seen. The rapid promotion of various intelligent devices usually needs the cooperation of rapid decline of other cost ends. After overcapacity occurs in the middle and upper reaches of electric vehicles, the speed of vehicle intelligence will be accelerated, and it remains under observation at present. In addition, after the release of semiconductor manufacturing capacity, various semiconductor materials may have investment opportunities.
From the top ten heavyweight stocks of the fund, in the fourth quarter of last year, Shi Cheng focused on adding positions of Yongxing Special Materials Technology Co.Ltd(002756) , Tianqi Lithium Corporation(002466) , Jiangxi Special Electric Motor Co.Ltd(002176) , Youngy Co.Ltd(002192) , Hoshine Silicon Industry Co.Ltd(603260) , Dongyue Group, etc. In addition, Tibet Mineral Development Co.Ltd(000762) , Qinghai Salt Lake Industry Co.Ltd(000792) , Chengxin Lithium Group Co.Ltd(002240) have become the top ten heavyweight stocks of the fund.
